TUESDAY, Feb. 28, 2023 (HealthDay Now) — A long-established Alzheimer’s drug can help people with a disorder that causes them to compulsively pull at their hair or pick at their skin, a new clinical trial has concluded....

The U.S. Food and Drug Administration said Tuesday that it has taken action to restrict imports of the veterinary tranquilizer xylazine to prevent illicit use of the drug. While veterinarians use products containing xylazine to sedate large...

Twenty percent of folks who are at high risk for heart disease refuse statins that could help prevent it, researchers report. They found that women were about 20% more likely than men to decline statin drugs when...

Actor Tom Sizemore, who suffered a brain aneurysm last week, remains in critical condition and doctors have told the family there is “no further hope.” Quoting Sizemore’s manager, CBS News reported that doctors have recommended his family...

Sen. John Fetterman will continue to be away from the U.S. Senate for several weeks but he is on the “path to recovery,” his spokesman said Monday. The senator is being treated for clinical depression at Walter...

Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows. Researchers found that of U.S. adults with the blood sugar disease, over 80% could stand...

If it’s good for your heart, it’s good for your brain, too. This is the main message from a new study showing that seven heart-healthy habits can lower your chances of developing dementia down the road. This...

TUESDAY, Feb. 28, 2023 (HealthDay News) – Whether women will continue to be able to get a medication abortion using the drug mifepristone in the United States hinges on the impending ruling of a federal judge in...

Though BRCA1 or BRCA2 gene mutations are associated with breast and ovarian cancer in younger women, those over 50 continue to have a high risk of breast cancer. That’s true even if they didn’t have breast cancer...

When Black patients struggle with dementia, they are less likely to receive helpful medications than their white peers, a new study warns. Researchers looked at how often patients received one or more of five classes of medications...